Aptamer selection and development services

Aptamer Group specializes in the development of Optimer® binders, which are advanced aptamers designed to provide high affinity, specificity, and stability for various applications in the life sciences. These next-generation binders are tailored for a wide range of uses, including therapeutics, diagnostics, and biomanufacturing processes. The company leverages its extensive experience and cutting-edge high-throughput automated technologies to create custom Optimer solutions that meet the specific needs of its international clientele. This innovative approach enables Aptamer Group to support projects aimed at identifying new biomarkers, enhancing drug delivery systems, and improving diagnostic tests.

The Optimer® platform is versatile and supports collaborations with numerous partners across the life sciences sector. Current projects include the development of Optimer® binders for targeted delivery of siRNA in partnership with AstraZeneca, as well as binders for cosmetic applications with Unilever. Additionally, Aptamer Group is working on diagnostic solutions for Alzheimer’s disease with Neuro-Bio Ltd and developing affinity resins for biomanufacturing with Bio-Works Technologies AB. These partnerships highlight the company's commitment to advancing healthcare and biotechnology through the application of its proprietary Optimer® technology, which is designed to facilitate the development of novel therapeutics and diagnostics.

United Kingdom

Aptamer Group develops Optimer® binders to enable innovation in the life science industry.  
 
Get our newsletter: https://aptamergroup.com/newsletter

Aptamer Group

Company Details